The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity
Ruth F. Rocha, Tiago Rodrigues, Angela C.O. Menegatti, Gonçalo J. L. Bernardes, Hernán Terenzi
Topics & Concepts
ChemistryPharmacologyInsulin resistanceIn vivoMechanism of actionInsulinDrugMetforminRosiglitazoneGlucose uptakePeroxisome proliferator-activated receptorProtein tyrosine phosphataseType 2 Diabetes MellitusDiabetes mellitusIn vitroReceptorEndocrinologyBiochemistryBiologyBiotechnologyProtein Tyrosine PhosphatasesGalectins and Cancer BiologyGenomics, phytochemicals, and oxidative stress